Stock listing
Stuttgart:2VJ Ascletis Pharma, Inc. Aktie
German listing (Stuttgart) of Ascletis Pharma, Inc. · home listing HKEX:1672
Follow Ascletis Pharma, Inc. into a list and get an email when it puts out news.
Share price · SWB:2VJ
€0.494 EUR +0.012 (+2.5%)
Close on Nov 17, 2026
- Day range
- €0.492 – €0.494 EURNov 17, 2026
- Market cap
- €1.03B EURAt the close on Nov 17, 2026 · price × 2.08B shares outstanding
- 52-week range
- €0.476 – €2.040 EURLowest and highest trades, Nov 18, 2025 – Nov 17, 2026
- Traded on an average day
- €202 EURMedian day 0 shares · 55 days with no trades · last 3 months, Aug 17, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| HKEX:1672 · Home | $4.37 HKD | +0.005 (+0.1%) | 585,080 | $4.365 | $4.50 | $4.175 | $4.365 | Close on Nov 18, 2026 |
| OTC:ASCLF | $0.625 USD | -0.095 (-13.2%) | 5,350 | $0.620 | $0.625 | $0.620 | $0.720 | Close on Nov 10, 2026 |
| Frankfurt:2VJ | €0.494 EUR | +0.010 (+2.1%) | — | €0.496 | €0.496 | €0.494 | €0.484 | Close on Nov 17, 2026 |
| Stuttgart:2VJ | €0.494 EUR | +0.012 (+2.5%) | — | €0.494 | €0.494 | €0.492 | €0.482 | Close on Nov 17, 2026 |
Daily closes
Last 3 months, Aug 17, 2026 – Nov 6, 2026 · SWB:2VJ · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €0.510 | -0.035 | -6.4% | €0.510 | €0.510 | €0.505 | 0 | |
| €0.545 | +0.035 | +6.9% | €0.540 | €0.545 | €0.540 | 0 | |
| €0.510 | +0.034 | +7.1% | €0.496 | €0.510 | €0.494 | 0 | |
| €0.476 | -0.044 | -8.5% | €0.486 | €0.488 | €0.476 | 0 | |
| €0.520 | -0.025 | -4.6% | €0.525 | €0.530 | €0.496 | 0 | |
| €0.545 | -0.035 | -6.0% | €0.550 | €0.550 | €0.545 | 0 | |
| €0.580 | -0.030 | -4.9% | €0.590 | €0.590 | €0.580 | 0 | |
| €0.610 | +0.010 | +1.7% | €0.615 | €0.620 | €0.610 | 0 | |
| €0.600 | -0.025 | -4.0% | €0.605 | €0.610 | €0.600 | 0 | |
| €0.625 | -0.010 | -1.6% | €0.620 | €0.625 | €0.620 | 0 | |
| €0.635 | +0.020 | +3.3% | €0.625 | €0.635 | €0.620 | 0 | |
| €0.615 | -0.050 | -7.5% | €0.610 | €0.620 | €0.605 | 0 | |
| €0.665 | +0.025 | +3.9% | €0.660 | €0.665 | €0.655 | 0 | |
| €0.640 | -0.010 | -1.5% | €0.660 | €0.660 | €0.640 | 0 | |
| €0.650 | 0.000 | 0.0% | €0.655 | €0.655 | €0.650 | 0 | |
| €0.650 | +0.005 | +0.8% | €0.665 | €0.665 | €0.650 | 0 | |
| €0.645 | -0.010 | -1.5% | €0.650 | €0.665 | €0.635 | 1,700 | |
| €0.655 | -0.090 | -12.1% | €0.690 | €0.690 | €0.650 | 6,566 | |
| €0.745 | -0.020 | -2.6% | €0.755 | €0.760 | €0.745 | 0 | |
| €0.765 | -0.010 | -1.3% | €0.765 | €0.775 | €0.760 | 6,566 | |
| €0.775 | -0.060 | -7.2% | €0.785 | €0.795 | €0.775 | 0 | |
| €0.835 | -0.110 | -11.6% | €0.860 | €0.860 | €0.835 | 0 | |
| €0.945 | -0.065 | -6.4% | €0.960 | €0.960 | €0.945 | 0 | |
| €1.010 | +0.100 | +11.0% | €1.010 | €1.020 | €1.000 | 0 | |
| €0.910 | +0.005 | +0.6% | €0.930 | €0.930 | €0.910 | 0 | |
| €0.905 | -0.030 | -3.2% | €0.895 | €0.915 | €0.895 | 0 | |
| €0.935 | +0.010 | +1.1% | €0.930 | €0.935 | €0.925 | 0 | |
| €0.925 | +0.010 | +1.1% | €0.910 | €0.940 | €0.905 | 0 | |
| €0.915 | -0.020 | -2.1% | €0.925 | €0.940 | €0.915 | 0 | |
| €0.935 | 0.000 | 0.0% | €0.905 | €0.945 | €0.895 | 0 | |
| €0.935 | -0.025 | -2.6% | €0.940 | €0.980 | €0.930 | 1,000 | |
| €0.960 | -0.050 | -5.0% | €0.960 | €0.970 | €0.960 | 0 | |
| €1.010 | +0.025 | +2.5% | €0.985 | €1.020 | €0.985 | 0 | |
| €0.985 | -0.025 | -2.5% | €0.970 | €0.995 | €0.965 | 0 | |
| €1.010 | +0.060 | +6.3% | €1.010 | €1.040 | €1.000 | 0 | |
| €0.950 | +0.065 | +7.3% | €0.950 | €0.975 | €0.945 | 0 | |
| €0.885 | -0.015 | -1.7% | €0.885 | €0.900 | €0.875 | 0 | |
| €0.900 | -0.070 | -7.2% | €0.905 | €0.915 | €0.890 | 0 | |
| €0.970 | -0.005 | -0.5% | €0.925 | €0.980 | €0.925 | 0 | |
| €0.975 | -0.065 | -6.3% | €0.975 | €0.975 | €0.975 | 0 | |
| €1.040 | -0.030 | -2.8% | €1.040 | €1.040 | €1.040 | 0 | |
| €1.070 | -0.060 | -5.3% | €1.100 | €1.100 | €1.070 | 0 | |
| €1.130 | +0.040 | +3.7% | €1.090 | €1.130 | €1.080 | 0 | |
| €1.090 | -0.020 | -1.8% | €1.080 | €1.120 | €1.080 | 0 | |
| €1.110 | +0.010 | +0.9% | €1.110 | €1.150 | €1.110 | 0 | |
| €1.100 | -0.010 | -0.9% | €1.110 | €1.120 | €1.100 | 0 | |
| €1.110 | +0.030 | +2.8% | €1.080 | €1.120 | €1.080 | 0 | |
| €1.080 | +0.050 | +4.9% | €1.070 | €1.100 | €1.070 | 0 | |
| €1.030 | 0.000 | 0.0% | €1.030 | €1.040 | €1.030 | 0 | |
| €1.030 | -0.050 | -4.6% | €1.030 | €1.040 | €1.030 | 0 | |
| €1.080 | -0.040 | -3.6% | €1.080 | €1.090 | €1.080 | 0 | |
| €1.120 | +0.060 | +5.7% | €1.100 | €1.130 | €1.090 | 0 | |
| €1.060 | 0.000 | 0.0% | €1.070 | €1.070 | €1.060 | 0 | |
| €1.060 | +0.030 | +2.9% | €1.060 | €1.070 | €1.050 | 0 | |
| €1.030 | -0.040 | -3.7% | €1.030 | €1.050 | €1.030 | 0 | |
| €1.070 | -0.030 | -2.7% | €1.070 | €1.080 | €1.070 | 0 | |
| €1.100 | +0.040 | +3.8% | €1.110 | €1.110 | €1.090 | 680 | |
| €1.060 | -0.020 | -1.9% | €1.070 | €1.080 | €1.050 | 0 | |
| €1.080 | -0.050 | -4.4% | €1.120 | €1.130 | €1.080 | 0 | |
| €1.130 | 0.000 | 0.0% | €1.120 | €1.130 | €1.110 | 0 |
- Ticker
- Stuttgart:2VJ
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Stuttgart
- Currency
- EUR
What changed lately
Latest news release · Nov 17, 2026
Voluntary announcement - ascletis submits IND application to the U.S. FDA for ASC36_37O FDC, a potentially first-in-class once-weekly oral quadruple peptide agonist targeting amylin receptor, GLP-1R, GIPR and GCGR, for the treatment of obesity
Latest deck · November 2026
Investor Presentation (November 2026)
Investor deck · 23 slides
Latest news
Next Day Disclosure Return
Nov 6, 2026
Closed €0.51 (-6.4%) on Nov 6, 2026
Grant of share options
Nov 4, 2026
Closed €0.51 (+7.1%) on Nov 4, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
Nov 4, 2026
Closed €0.51 (+7.1%) on Nov 4, 2026
Voluntary announcement - ascletis to present study results of oral small molecule GIPR agonist ASC48 and GLP-1R/GIPR/GCGR triple peptide agonist ASC37 at ObesityWeek 2026
Nov 2, 2026
Closed €0.52 (-4.6%) on Nov 2, 2026
Voluntary announcement - ascletis' oral small molecule GLP-1, ASC30, demonstrated placebo-adjusted HBA1C reduction of 1.7% at 12 weeks from its U.S. phase II study in participants with diabetes
Oct 28, 2026
Closed €0.58 (-4.9%) on Oct 29, 2026
Decks
Investor Presentation (November 2026)
Investor deck · 23 slides · November 2026
Investor Presentation (October 2026)
Investor deck · 23 slides · Oct 21, 2026
Investor Presentation (August 2026)
Investor deck · 22 slides · August 2026
EASD 2026
Conference · 8 slides · 2026
Ascletis Pharma, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 57 in the last 12 months · 88 in all · newest Nov 17, 2026 · oldest 2025
- Decks
- 6 decks · latest November 2026
Where Ascletis Pharma, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| HKEX:1672 歌禮製藥 · Home listing | HKEX | Hong Kong | HKD |
| Tradegate:2VJ | Tradegate | Germany | EUR |
| OTC:ASCLF | OTC | United States | USD |
| LS Exchange:A2JRKN | LS Exchange | Germany | EUR |
| gettex:2VJ | gettex | Germany | EUR |
| Lang & Schwarz:A2JRKN | Lang & Schwarz | Germany | EUR |
| Frankfurt:2VJ | Frankfurt | Germany | EUR |
| Dusseldorf:2VJ | Dusseldorf | Germany | EUR |
| Munich:2VJ | Munich | Germany | EUR |
| Stuttgart:2VJ · This page | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Ascletis Pharma, Inc.